Press Releases Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Delayed Nasdaq Other stock markets 18:36:08 16/05/2024 BST			5-day change	1st Jan Change
0.81 ^USD	+0.25%		-21.17%	-89.85%

05-08	Aptevo Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	US Equity Markets Close Mixed After March Producer Price Inflation Data	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update	05-09	AQ
Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update	05-06	AQ
Aptevo Therapeutics : 2024 Shareholder Letter	04-26	PU
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering	04-16	AQ
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering	04-12	AQ
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	03-07	AQ
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update	03-06	AQ
Alligator Bioscience AB reports full year financial results for 2023 and for Q4 2023 and provides a business update	02-08	AQ
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update	11-15	AQ
Aptevo to Present at Bio-Europe Conference	11-02	AQ
Aptevo Therapeutics : 28 August 2023 Investor Presentation	28/08/23	PU
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update	11/08/23	AQ
Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering	07/08/23	AQ
Aptevo Therapeutics : Material Agreement - Form 8-K	07/08/23	PU
CapitalGainsReport Nanocap News Catalyst Watchlist (EPAZ, SIDU, MMMM, APVO)	20/07/23	AQ
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML	19/07/23	AQ
Aptevo Therapeutics : New Data Adds to Growing Body of Clinical Evidence in Support of APVO436 Clinical Potential - Form 8-K	18/07/23	PU
Aptevo Therapeutics : 11 July 2023 Investor Presentation	11/07/23	PU
Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update	12/05/23	AQ
APTEVO THERAPEUTICS INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	11/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Press Releases

Filters